BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25976207)

  • 1. M410, a combretastatin A4 analogue, disrupts microtubules and inhibits HIF-1α in human breast cancer cells.
    Yang H; Xia Q; Zou Y; Wang K; Jiang W; Cai Y
    Oncol Rep; 2015 Jul; 34(1):334-40. PubMed ID: 25976207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor activity and mechanisms of a novel vascular disrupting agent, (Z)-3,4',5-trimethoxylstilbene-3'-O-phosphate disodium (M410).
    Cai YC; Zou Y; Ye YL; Sun HY; Su QG; Wang ZX; Zeng ZL; Xian LJ
    Invest New Drugs; 2011 Apr; 29(2):300-11. PubMed ID: 20012336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
    Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
    Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early growth response gene-1 and hypoxia-inducible factor-1α affect tumor metastasis via regulation of tissue factor.
    Sun L; Liu Y; Lin S; Shang J; Liu J; Li J; Yuan S; Zhang L
    Acta Oncol; 2013 May; 52(4):842-51. PubMed ID: 23409769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells.
    Zhao Q; Du J; Gu H; Teng X; Zhang Q; Qin H; Liu N
    Pancreas; 2007 Mar; 34(2):242-7. PubMed ID: 17312464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
    Welsh SJ; Bellamy WT; Briehl MM; Powis G
    Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
    Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel resveratrol analogue, HS-1793, inhibits hypoxia-induced HIF-1α and VEGF expression, and migration in human prostate cancer cells.
    Kim DH; Hossain MA; Kim MY; Kim JA; Yoon JH; Suh HS; Kim GY; Choi YH; Chung HY; Kim ND
    Int J Oncol; 2013 Dec; 43(6):1915-24. PubMed ID: 24100602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].
    Wu Q; Yang SH; Wang RY; Ye SN; Xia T; Ma DZ
    Ai Zheng; 2005 May; 24(5):531-5. PubMed ID: 15890092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect and mechanism of apigenin on VEGF expression in human breast cancer cells].
    Jin XY; Ren CS
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):495-9. PubMed ID: 18069627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of hypoxia-inducible factor-1 alpha reduces proliferation, induces apoptosis and attenuates the aggressive phenotype of retinoblastoma WERI-Rb-1 cells under hypoxic conditions.
    Xia T; Cheng H; Zhu Y
    Ann Clin Lab Sci; 2014; 44(2):134-44. PubMed ID: 24795051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ascofuranone suppresses EGF-induced HIF-1α protein synthesis by inhibition of the Akt/mTOR/p70S6K pathway in MDA-MB-231 breast cancer cells.
    Jeong YJ; Cho HJ; Magae J; Lee IK; Park KG; Chang YC
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):542-50. PubMed ID: 24096035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diallyl trisulfides, a natural histone deacetylase inhibitor, attenuate HIF-1α synthesis, and decreases breast cancer metastasis.
    Wei Z; Shan Y; Tao L; Liu Y; Zhu Z; Liu Z; Wu Y; Chen W; Wang A; Lu Y
    Mol Carcinog; 2017 Oct; 56(10):2317-2331. PubMed ID: 28574600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol abrogates the effects of hypoxia on cell proliferation, invasion and EMT in osteosarcoma cells through downregulation of the HIF-1α protein.
    Sun Y; Wang H; Liu M; Lin F; Hua J
    Mol Med Rep; 2015 Mar; 11(3):1975-81. PubMed ID: 25384583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.
    Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG
    Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells.
    Cao Z; Fang J; Xia C; Shi X; Jiang BH
    Clin Cancer Res; 2004 Aug; 10(15):5253-63. PubMed ID: 15297429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HS-1793, a resveratrol analogue, downregulates the expression of hypoxia-induced HIF-1 and VEGF and inhibits tumor growth of human breast cancer cells in a nude mouse xenograft model.
    Kim DH; Sung B; Kim JA; Kang YJ; Hwang SY; Hwang NL; Suh H; Choi YH; Im E; Chung HY; Kim ND
    Int J Oncol; 2017 Aug; 51(2):715-723. PubMed ID: 28656256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FBP1 modulates cell metabolism of breast cancer cells by inhibiting the expression of HIF-1α.
    Shi L; He C; Li Z; Wang Z; Zhang Q
    Neoplasma; 2017; 64(4):535-542. PubMed ID: 28485159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melittin inhibits the expression of key genes involved in tumor microenvironment formation by suppressing HIF-1α signaling in breast cancer cells.
    Mir Hassani Z; Nabiuni M; Parivar K; Abdirad S; Karimzadeh L
    Med Oncol; 2021 Jun; 38(7):77. PubMed ID: 34076777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF-1α decoy oligodeoxynucleotides inhibit HIF-1α signaling and breast cancer proliferation.
    Zhu X; Li Q; Li S; Chen B; Zou H
    Int J Oncol; 2015 Jan; 46(1):215-22. PubMed ID: 25334080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.